Colchicine induces apoptosis in HT-29 human colon cancer cells via the AKT and c-Jun N-terminal kinase signaling pathways
Authors:
- 12 August 2015
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 12 (4) , 5939-5944
Abstract
Colchicine is a natural compound, which belongs to the botanical family Colchicaceae and prevents growth of cancer cells via antimitotic activity by interacting with microtubules. Although numerous studies have demonstrated that the effect of colchicine on cell apoptosis is mediated by the activation of caspase‑3, the signaling pathways involved in the process remain unknown. In the current study, evidence is presented regarding the missing information using HT‑29 human colon cancer cells. The effect of colchicine on apoptosis in HT‑29 cells and the apoptosis‑associated signaling pathways were determined using various methods, including cell viability assay, Annexin V/propidium idodide (PI) binding, PI staining, Hoechst 33342 staining, mitochondrial membrane potential (Δψm) assay, reactive oxygen species (ROS) assay and western blot analysis. Colchicine was observed to induce a dose‑dependent reduction in cell viability in HT‑29 cells and early apoptosis occurred when the cells were treated with 1 µg/ml colchicine. Furthermore, colchicine treatment induced a loss of Δψm, increased ROS production, activated caspase‑3, upregulated BAX expression and downregulated Bcl‑2 expression, which evidenced the colchicine activity on apoptosis, potentially by acting via the intrinsic apoptotic signaling pathway. Colchicine increased phosphorylation of p38, although not phosphorylation of extracellular signal-regulated kinase and c-Jun N-terminal kinase, which indicates that colchicine activates the p38 signaling pathway in order to induce cell apoptosis. Therefore, colchicine exhibited significant growth inhibition of the HT‑29 colon cancer cell line and induced apoptosis in the cells via the mitochondrial pathway, which is regulated by p38 signaling pathways.Keywords
This publication has 21 references indexed in Scilit:
- Challenges in the Management of Stage II Colon CancerSeminars in Oncology, 2011
- Effectiveness of Adjuvant Chemotherapy with 5-FU/Leucovorin and Prognosis in Stage II Colon CancerJournal of the Korean Society of Coloproctology, 2011
- Taccalonolides: Novel microtubule stabilizers with clinical potentialCancer Letters, 2010
- Microtubule dynamics as a target in oncologyCancer Treatment Reviews, 2009
- Anti‐mitotic activity of colchicine and the structural basis for its interaction with tubulinMedicinal Research Reviews, 2007
- Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression ProfilingJournal of Clinical Oncology, 2006
- T Cells a Boon for Colon Cancer PrognosisScience, 2006
- Microtubules as a target for anticancer drugsNature Reviews Cancer, 2004
- Insight into tubulin regulation from a complex with colchicine and a stathmin-like domainNature, 2004
- Modifiable risk factors for colon cancerGastroenterology Clinics of North America, 2002